KCNK9（potassium two pore domain channel subfamily K member 9) encodes a protein that contains multiple transmembrane regions and two pore-forming P domains and functions as a pH-dependent potassium channel. Amplification and overexpression of KCNK9 have been observed in several types of human carcinomas. KCNK9 is imprinted in the brain, with preferential expression from the maternal allele. A mutation in KCNK9 was associated with Birk-Barel mental retardation dysmorphism syndrome. Alternative splicing results in multiple transcript variants.

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB: 1:1000-2000, IHC-p: 1:100-200.

KCNK9 (TASK-3) Polyclonal Antibody product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Find more details at http://www.abbkine.com/product/kcnk9-task-3-polyclonal-antibody-abp57332.